DE60126337D1 - Verfahren zum screenen für gpr40-liganden - Google Patents

Verfahren zum screenen für gpr40-liganden

Info

Publication number
DE60126337D1
DE60126337D1 DE60126337T DE60126337T DE60126337D1 DE 60126337 D1 DE60126337 D1 DE 60126337D1 DE 60126337 T DE60126337 T DE 60126337T DE 60126337 T DE60126337 T DE 60126337T DE 60126337 D1 DE60126337 D1 DE 60126337D1
Authority
DE
Germany
Prior art keywords
screening
ligands
gpr40
gpr40 ligands
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60126337T
Other languages
English (en)
Other versions
DE60126337T2 (de
Inventor
Leon Andrews
Patricia Briscoe
Michelle Ignar
Isobel Muir
Ray Sauls Jr
Mohammad Tadayyon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Glaxo Group Ltd
Original Assignee
SmithKline Beecham Ltd
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd, Glaxo Group Ltd filed Critical SmithKline Beecham Ltd
Application granted granted Critical
Publication of DE60126337D1 publication Critical patent/DE60126337D1/de
Publication of DE60126337T2 publication Critical patent/DE60126337T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/10Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE60126337T 2000-12-22 2001-12-18 Verfahren zum screenen für gpr40-liganden Expired - Lifetime DE60126337T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0031527.5A GB0031527D0 (en) 2000-12-22 2000-12-22 New use
GB0031527 2000-12-22
PCT/US2001/048985 WO2002057783A2 (en) 2000-12-22 2001-12-18 Method of screening for gpr40 ligands

Publications (2)

Publication Number Publication Date
DE60126337D1 true DE60126337D1 (de) 2007-03-15
DE60126337T2 DE60126337T2 (de) 2007-11-15

Family

ID=9905799

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60126337T Expired - Lifetime DE60126337T2 (de) 2000-12-22 2001-12-18 Verfahren zum screenen für gpr40-liganden

Country Status (7)

Country Link
EP (1) EP1354200B1 (de)
AT (1) ATE352784T1 (de)
AU (1) AU2002246702A1 (de)
DE (1) DE60126337T2 (de)
ES (1) ES2280427T3 (de)
GB (1) GB0031527D0 (de)
WO (1) WO2002057783A2 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1479768B1 (de) 2002-02-14 2010-04-28 Takeda Pharmaceutical Company Limited Neues screening-verfahren
AU2003261935A1 (en) * 2002-09-06 2004-03-29 Takeda Pharmaceutical Company Limited Furan or thiophene derivative and medicinal use thereof
US7056685B1 (en) 2002-11-05 2006-06-06 Amgen Inc. Receptor ligands and methods of modulating receptors
AU2003277576A1 (en) * 2002-11-08 2004-06-07 Takeda Pharmaceutical Company Limited Receptor function controlling agent
WO2004050853A2 (en) * 2002-12-04 2004-06-17 Synaptic Pharmaceutical Corporation Uses of the snorf55 receptor
WO2004065960A1 (ja) 2003-01-17 2004-08-05 Takeda Pharmaceutical Company Limited 新規スクリーニング方法
JP4574177B2 (ja) * 2003-01-17 2010-11-04 武田薬品工業株式会社 新規スクリーニング方法
US20060160088A1 (en) * 2003-02-17 2006-07-20 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 40 (gpr40)
US7820837B2 (en) 2003-05-30 2010-10-26 Takeda Pharmaceutical Company Limited Condensed ring compound
US20070011755A1 (en) * 2003-08-18 2007-01-11 Betagnon Ab Diabetes type 2 animal model
US7834013B2 (en) 2003-11-19 2010-11-16 Glaxosmithkline Llc Aminophenylcyclopropyl carboxylic acids and derivatives as agonists to GPR40
EP1737809B1 (de) 2004-02-27 2013-09-18 Amgen, Inc Verbindungen, pharmazeutische zusammensetzungen und verfahren zur verwendung bei der behandlung von stoffwechselstörungen
US7517910B2 (en) 2004-03-30 2009-04-14 Takeda Pharmaceutical Company Limited Alkoxyphenylpropanoic acid derivatives
US20060003344A1 (en) * 2004-06-30 2006-01-05 Pfizer Inc. Methods related to a single nucleotide polymorphism of the G protein coupled receptor, GPR40
JP2007284350A (ja) 2004-07-27 2007-11-01 Takeda Chem Ind Ltd 糖尿病治療剤
US7465804B2 (en) 2005-05-20 2008-12-16 Amgen Inc. Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders
AU2006291234A1 (en) 2005-09-14 2007-03-22 Amgen Inc. Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders
US8252521B2 (en) 2005-11-04 2012-08-28 Eisai R&D Management Co., Ltd. Method of screening substance useful in treating disease with the use of GPR40 and phospholipase
WO2008030520A1 (en) 2006-09-07 2008-03-13 Amgen Inc. Heterocyclic gpr40 modulators
WO2008030618A1 (en) 2006-09-07 2008-03-13 Amgen Inc. Benzo-fused compounds for use in treating metabolic disorders
JP2010524932A (ja) 2007-04-16 2010-07-22 アムジエン・インコーポレーテツド 置換ビフェニルフェノキシ−、チオフェニル−及びアミノフェニルプロパン酸gpr40調節物質
WO2009048527A1 (en) 2007-10-10 2009-04-16 Amgen Inc. Substituted biphenyl gpr40 modulators
JP2011515341A (ja) 2008-03-06 2011-05-19 アムジエン・インコーポレーテツド 代謝障害の治療に有用な立体配座的に制限されたカルボン酸誘導体
CA2739888C (en) 2008-10-15 2013-11-19 Amgen Inc. Spirocyclic gpr40 modulators
PL233938B1 (pl) * 2018-01-08 2019-12-31 CELON PHARMA Spólka Akcyjna Pochodne kwasu 3-fenylo-4-heksynowego jako agoniści GPR40

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6309854B1 (en) * 1996-12-17 2001-10-30 Smithkline Beecham Corporation Polynucleotides encoding ligands of the neuropeptide receptor HFGAN72
US6555339B1 (en) * 1997-04-14 2003-04-29 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human protein-coupled receptors
WO2002044362A1 (fr) * 2000-12-01 2002-06-06 Yamanouchi Pharmaceutical Co., Ltd. Procede de depistage d'un remede

Also Published As

Publication number Publication date
AU2002246702A1 (en) 2002-07-30
EP1354200B1 (de) 2007-01-24
ATE352784T1 (de) 2007-02-15
GB0031527D0 (en) 2001-02-07
DE60126337T2 (de) 2007-11-15
WO2002057783A2 (en) 2002-07-25
ES2280427T3 (es) 2007-09-16
WO2002057783A3 (en) 2003-08-07
EP1354200A2 (de) 2003-10-22

Similar Documents

Publication Publication Date Title
DE60126337D1 (de) Verfahren zum screenen für gpr40-liganden
DE50204719D1 (de) Verfahren zum bereitstellen von leistungsmerkmalen für alternativ-verbindungen von primär-verbindungen
DE50111437D1 (de) Verfahren zum einbringen von zuschlagstoffen (additiven)
ATA8612001A (de) Verfahren zum testen von software
DE60006067D1 (de) Entfernbarer filter für schlamm, kohlenwasserstoffsyntheseverfahren
DE60020163D1 (de) Fotomaske, verfahren zu ihrer herstellung
DE60038856D1 (de) Herstellungsverfahren für Toner
DE60116009D1 (de) Verfahren zum herstellen von reduziertem eisen
DE60132243D1 (de) Verfahren zum indizieren von entitäten
ATE230726T1 (de) Verfahren um diaryl-pyridine zu herstellen, die als cox-inhibitoren verwendbar sind
EA200001129A3 (ru) Способ получения 4-карбоксиамино-2-замещенного-1,2,3,4-тетрагидрохинолина
DE69910464D1 (de) Verfahren zum Verbinden von unterschiedlichen Elementen
DE60317136D1 (de) Immuntestverfahren, Reagenz für Immuntestverfahren und Verfahren zu dessen Herstellung
DE60314955D1 (de) Verfahren zur Inspektion von Dampfturbinen
DE60142344D1 (de) Schweiss-herstellungsverfahren für einen elektrolyseur
DE60131525D1 (de) Verfahren zum screening von inhibitoren für osteopontin
DE60136355D1 (de) Verfahren zum entwickeln von werkzeugen
DE50102671D1 (de) Diethyloctandioldicarbamate und diethyloctandioldiallophanate, verfahren zu ihrer herstellung und ihre verwendung
DE60044618D1 (de) Verfahren zum verbinden von strickwaren
DE602004022156D1 (de) Verfahren zum verbinden von strickwaren
ATE255820T1 (de) Verfahren zum pelletieren
DE502004008042D1 (de) Verfahren zum umformen von blechen
DE60023243D1 (de) Verfahren zum Erzeugen von gleichmässigem Glanz
DE60131397D1 (de) Verfahren zur gewinnung von cetamin-enantiomeren.
DE602004014217D1 (de) Verfahren für die Wiedergewinnung von Land Vorvertiefung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition